To measure the effect of the digital picture based Patient Benefit Assessment Scale on patient-centred outcomes regarding their health care process, the first eight domains of the factor health care process of the PPPC-R questionnaire (appendix 2)…
ID
Source
Brief title
Condition
- Joint disorders
- Miscellaneous and site unspecified neoplasms benign
- Arteriosclerosis, stenosis, vascular insufficiency and necrosis
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
To measure the effect of the digital picture based Patient Benefit Assessment
Scale on patient-centred outcomes regarding their health care process, the
first eight domains of the factor health care process of the PPPC-R
questionnaire (appendix 2) are asked after the outpatient consult, and at three
and six months.
Secondary outcome
• To assess whether the use of the digital picture based Patient Benefit
Assessment Scale improves the level of shared decision making. The I-Share
questionnaire (appendix 3) is asked after the outpatient consult.
• To assess whether the use of the digital picture baseds Patient Benefit
Assessment Scale improves the quality of life of patients, measured with the
SF-36 (appendix 4) at baseline and after three and six months after the first
outpatient consult. level of shared decision making during the consultation
experienced by patients.
• To study the cost effectiveness of the digital picture based Patient Benefit
Assessment Scale, measured with the EQ-5D-5L (appendix 5) at baseline and after
three and six months after the first outpatient consult.
• To examine whether the chosen treatment options of the intervention group
differ from those of the control group. Based on the (electronic patient
record the chosen treatment options can be analysed. The final comparison
between treatments of the intervention group and the treatments of the control
group is made after six months. ).
Background summary
The prevalence of multimorbidity and chronic health conditions is increasing in
patients aged 65 years and older. Multimorbidity and the complexity of health
conditions have an impact on the shared decision making (SDM) process between
patients and healthcare professionals. The patient*s goals are an important
factor in SDM. The SDM process and thereby setting health oriented goals, is
especially complex in older patients, often dealing with physical and cognitive
impairments or low health literacy. Goals of treatment are often multi-layered,
implicit and can therefore conflict with each other or with different treatment
options. However, there is currently little or limited focus on the goals that
are important to patients* SDM. It thereby raises the question whether current
care, where healthcare professionals suggest treatment options, fits the goals,
aims, preferences and needs of older patients. With the increased focus on
personalized care and SDM, the Patient Benefit Assessment Scale for
Hospitalised Older Patients (P-BAS HOP) has been developed. The P-BAS HOP has
been designed to better meet the needs and identify the goals of acutely
hospitalised elderly patients with multimorbidity. As a follow-up, in order to
support patients with low literacy and increase the acceptability, a picture
based P-BAS (P-BAS-P) was developed. Although literature shows promising
strategies leading to improving SDM, relatively little is known about the
effect of better including patient goals in SDM in an outpatient setting on
patient centred outcomes, quality of life, treatment choice and cost
effectiveness.
Study objective
To measure the effect of the digital picture based Patient Benefit Assessment
Scale on patient-centred outcomes regarding their health care process, the
first eight domains of the factor health care process of the PPPC-R
questionnaire (appendix 2) are asked after the outpatient consult, and at three
and six months.
Study design
A randomised control trial.
Intervention
Before patients have their first outpatient consult, patients randomised into a
control group and an intervention group. Both groups are asked to fill in
questionnaires regarding their quality of life and a question regarding their
digital health literacy. The intervention group is also asked to fill in the
P-BAS questionnaire. Healthcare professionals are trained in using the P-BAS
and the outcomes of this questionnaire during the consult. In this way the
outcomes of the P-BAS can serve directly as input in the outpatient
consultation and treatment process. After the outpatient consult various
additional questionnaires are presented, concerning overall satisfaction with
the treatment process, quality of life and the level of shared decision making.
Study burden and risks
The burden and risks of participating in this study are negligible. Regarding
time investment, all participating patients will be asked to complete various
questionnaires over time, taking approximately a total of 60 minutes. In line
with the experiences of two previous studies including the P-BAS, we do not
expect any health risks to be associated with the use of the P-BAS. The
intervention that patients will receive (P-BAS), is expected to have a positive
effect on the level of patients* quality of life since the P-BAS implies to
contribute to the best personalized care.
Koningstraat 1
Enschede 7512 KZ
NL
Koningstraat 1
Enschede 7512 KZ
NL
Listed location countries
Age
Inclusion criteria
• Age >= 65 years
• Patients who can read, speak and understand the Dutch language
• Patients with an outpatient consult whereby the consultation is expected to
contain a decision with regard to treatment options
• Capable to fill in digital questionnaires and having access to the Internet
and DigiD
Exclusion criteria
- Cognitive limitations (e.g. delirium or dementia), as assessed by the health
care provider
- Patients without an email account
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL84861.100.24 |